Tag: CNTN Research Symposium

CNTN Research Symposium is now open!

Posted on

 

We are currently planning the next CNTN Research Symposium at the Canadian Society of Nephrology AGM Pre-course on Wednesday, May 7, 2025 from 8:30 a.m. – 11:30 a.m. PT. This is a great opportunity to learn about what CNTN has been up to, where it is going, and how to get involved!

Presentations at this year’s symposium will include:

  • Dr. Adeera Levin – EASI-Kidney:  A multicenter international randomized double-blind placebo-controlled clinical trial in patients with chronic kidney disease
  • Dr. David Cherney – SUGARNSALT: Sodium Glucose Co-Transport-2 Inhibition Diabetes and Kidney Function Loss in Type 1 Diabetes (SUGARNSALT) research project

Please note the CNTN Research Symposium is an open symposium, but spots are limited.

Take a moment to REGISTER HERE

Call for additional presenters  

We are seeking additional speakers for the CNTN Research Symposium, particularly those leading investigator-initiated trials, randomized controlled trials (RCTs), prospective observational studies, feasibility studies, or pediatric nephrology trials. We also welcome trainees and early career researchers, as well as individuals with early-stage project ideas. Don’t miss this great opportunity to present your project and receive valuable feedback from peers and experts in the field!

If you would like to present or have an idea, please contact Omo Enilama at oenilama@cansolveckd.ca

CNTN Research Symposium

We are currently planning the next CNTN Research Symposium at the Canadian Society of Nephrology AGM Pre-course on Wednesday, May 7, 2025 from 8:30 a.m. – 11:30 a.m. PT. This is a great opportunity to learn about what CNTN has been up to, where it is going, and how to get involved!

Presentations at this year’s symposium will include:

  • Dr. Adeera Levin – EASI-Kidney:  A multicenter international randomized double-blind placebo-controlled clinical trial in patients with chronic kidney disease
  • Dr. David Cherney – SUGARNSALT: Sodium Glucose Co-Transport-2 Inhibition Diabetes and Kidney Function Loss in Type 1 Diabetes (SUGARNSALT) research project

Please note the CNTN Research Symposium is an open symposium, but spots are limited.

Take a moment to REGISTER HERE

Call for additional presenters  

We are seeking additional speakers for the CNTN Research Symposium, particularly those leading investigator-initiated trials, randomized controlled trials (RCTs), prospective observational studies, feasibility studies, or pediatric nephrology trials. We also welcome trainees and early career researchers, as well as individuals with early-stage project ideas. Don’t miss this great opportunity to present your project and receive valuable feedback from peers and experts in the field!

If you would like to present or have an idea, please contact Omo Enilama at oenilama@cansolveckd.ca

Highlights from the 5th Annual CNTN Research Symposium

Posted on

The 5th annual Canadian Nephrology Trials Network (CNTN) Research Symposium took place on May 10, 2023, bringing together patients, providers, and researchers in a celebratory gathering. The event, held at the Canadian Society of Nephrology AGM, served as a platform to honour the achievements of CNTN and explore its future trajectory, while also presenting opportunities for engagement.
 

This half-day symposium showcased a diverse range of educational presentations by esteemed kidney researchers. These researchers, through their diligent efforts, are making significant contributions to our understanding and treatment of kidney disease.  

 

Presentations included:
 

Dr. Bhanu Prasad: Decoding loin pain hematuria syndrome (View video)
Dr. Prasad presented his ongoing research on loin pain hematuria syndrome. His team’s recent work includes phenotype analysis and pedigree chartings in LPHS as well as genomics. His website, www.prasadbhanu.com, has more information on his research program.
 

Dr. Amélie Bernier-Jean: Evidence for Potassium restriction in hemodialysis (EvoKe-HD) pilot (View video)
“EvoKe-HD is a pilot randomized controlled trial to assess the feasibility and potential for efficacy of a novel dietary approach to hyperkalemia. Contrary to the traditional recommendations limiting the intake of high-potassium whole foods, such as fruits and vegetables, we propose to switch the focus to foods containing potassium that is readily absorbed by the body (high bioavailability), such as potassium from additives, processed meats, milk, fruit juices and sugary drinks.”
 

Dr. Adeera Levin: New investigator-initiated trial 

Dr. Levin presented an upcoming investigator-initiated trial of an investigational drug that will be starting early next year.  

 

Dr. Morteza Ahmadi: Qidni labs innovative dialysis machine
Dr. Ahmadi presented Qidni Lab’s nearly waterless and portable dialysis machine currently conducting first-in-human dialysis sessions. Able to run on rechargeable batteries with remote, cloud-based monitoring, this machine could provide dialysis for those living in rural or remote areas or who have no or limited access to dialysis. For more information on their trial and device, visit www.qidni.life.  

CNTN Research Symposium

We are excited to see membership next month in Halifax at the Canadian Society of Nephrology AGM. The CNTN Research Symposium will take place on Wednesday, May 10, 2023 from 8 am – 11 am AST. This is a great opportunity to learn about what CNTN has been up to, where we are going, and how to get involved. The event will include research presentations.

Make sure to come visit us at our booth and take some of our new CNTN promotional material including print material below! 

CNTN Research Symposium 2022

Posted on

 

The Canadian Nephrology Trials Network (CNTN) Research Symposium was held on May 9 at the Canadian Society of Nephrology AGM. Co-moderated by Dr. Karthik Tennankore and Hans Vorster, attendees learned about what CNTN has been up to, where they are going, and how to get involved. The session included presentations from Dr. David Collister, Dr. Remi Goupil and Dr. Dylan MacKay.

Read CNTN Research Symposium Lay Summaries

WATCH RECORDING HERE